Standard treatment of primary hypothyroidism is with thyroxine, with the ai
m of relieving symptoms and bringing the serum TSH (thyroid-stimulating hor
mone) concentration to within the reference range.
Recent research suggests that in some patients symptoms of hypothyroidism p
ersist despite standard thyroxine replacement therapy. The optimal treatmen
t of these patients is not known. Adjusting the thyroxine dose until the se
rum TSH concentration is in the lower part of the reference range (eg, 0.3-
2.0 mU/L) may be beneficial.
Animal studies and a single small clinical trial suggest that a combination
of thyroxine and T-3 (triiodothyronine), rather than thyroxine alone, may
be required for optimal thyroid replacement therapy.
Further research is needed to determine why some patients appear to have a
suboptimal response to thyroxine, and whether combined thyroxine/T-3 treatm
ent is preferable to thyroxine alone in these patients.